UBS AM’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.86M Sell
207,826
-282,392
-58% -$4.26M ﹤0.01% 1859
2025
Q4
$8.84M Buy
+490,218
New +$8.8M ﹤0.01% 1174
2025
Q3
Sell
-288,736
Closed -$4.62M 2349
2025
Q2
$4.62M Buy
288,736
+115,723
+67% +$2.06M ﹤0.01% 1750
2025
Q1
$3.36M Buy
173,013
+24,881
+17% +$524K ﹤0.01% 1762
2024
Q4
$3.26M Buy
148,132
+36,341
+33% +$699K ﹤0.01% 1816
2024
Q3
$1.88M Buy
111,791
+11,730
+12% +$174K ﹤0.01% 2066
2024
Q2
$1.2M Buy
100,061
+63,661
+175% +$711K ﹤0.01% 2282
2024
Q1
$403K Hold
36,400
﹤0.01% 2342
2023
Q4
$315K Hold
36,400
﹤0.01% 2415
2023
Q3
$278K Hold
36,400
﹤0.01% 2452
2023
Q2
$222K Hold
36,400
﹤0.01% 2550
2023
Q1
$222K Hold
36,400
﹤0.01% 2550
2022
Q4
$159K Hold
36,400
﹤0.01% 2469
2022
Q3
$143K Hold
36,400
﹤0.01% 2649
2022
Q2
$186K Hold
36,400
﹤0.01% 2591
2022
Q1
$233K Buy
36,400
+5,400
+17% +$35.8K ﹤0.01% 2648
2021
Q4
$249K Buy
+31,000
New +$292K ﹤0.01% 2723

Other funds holding CLBT